SCHEDULE 13D: KKR Boosts Stake in Henry Schein to 9.7%, Secures Board Representation

Private equity giant KKR has significantly increased its beneficial ownership in Henry Schein Inc. to 9.7% and will appoint two designees to the company's Board of Directors as part of a new strategic partnership.

Summary

• KKR and its affiliated entities, collectively referred to as the Reporting Persons, now beneficially own an aggregate of 12,016,714 shares of Henry Schein Inc. Common Stock, representing approximately 9.7% of the outstanding shares.
• This ownership includes 11,628,344 shares held by KKR Hawaii Aggregator L.P. and 388,370 shares held by MH Sub I, LLC.
• The shares held by KKR Hawaii Aggregator L.P. were primarily acquired on March 13, 2025, through the physical settlement of a total return swap from an affiliate, Tarheel Investors II L.P., at an effective purchase price of approximately $74.75 per share.
• MH Sub I, LLC acquired its shares between February 21, 2023, and July 17, 2024, for an aggregate purchase price of approximately $24 million.
• Henry Schein Inc. entered into a Strategic Partnership Agreement with KKR Hawaii Aggregator L.P. on January 29, 2025, agreeing to issue and sell 3,285,152 shares in a private placement for $250 million, at a price of approximately $76.10 per share.
• As part of the partnership, Henry Schein will appoint two KKR designees, Max Lin and William K. 'Dan' Daniel, to its Board of Directors, expanding the board size to no more than 14 members.
• Max Lin will be appointed to the Nominating and Governance Committee as Vice Chair, and William K. 'Dan' Daniel will be appointed to the Compensation Committee; both will also join the Strategic Advisory Committee.
• KKR has agreed to certain standstill restrictions and voting commitments, which will remain in effect through February 20, 2026, or potentially February 20, 2027, if an extension election is made, and as long as any designee remains on the Board.
• A Registration Rights Agreement will be entered into, providing KKR with customary registration rights for its shares.

Sentiment

Score: 8

Explanation: The document reflects a strong positive sentiment. KKR, a major private equity firm, is making a significant strategic investment in Henry Schein, acquiring a substantial stake and securing board representation. This indicates confidence in Henry Schein's future and provides the company with a significant capital infusion and strategic guidance from a respected investor. The terms of the agreement, including board seats and standstill provisions, are standard for such partnerships.

Positives

• The strategic partnership with KKR, a prominent investment firm, signals strong confidence in Henry Schein's business and future prospects.
• The private placement of shares provides Henry Schein with $250 million in capital, strengthening its financial position.
• The appointment of two KKR designees to the Board, including positions on key committees (Nominating and Governance, Compensation, Strategic Advisory), suggests KKR will actively contribute to Henry Schein's strategic direction and corporate governance.
• The investment is for 'investment purposes,' indicating KKR's long-term interest in value creation for Henry Schein.

Risks

• The private placement and board appointments are subject to the satisfaction of customary conditions, including obtaining clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and any applicable foreign regulatory approvals.
• KKR's director nomination rights and the continued service of its designees are contingent on maintaining certain beneficial ownership thresholds (at least 7.5% for one designee, 5% for both).

Future Outlook

The Reporting Persons acquired the securities for investment purposes and intend to continuously review their investment in Henry Schein. They may acquire or dispose of additional shares, and plan to engage in ongoing discussions with Henry Schein's management and board regarding business, operations, strategy, plans, and prospects. The appointment of KKR designees to the board indicates a potential for KKR to influence Henry Schein's corporate activities and strategic direction.

Industry Context

KKR's significant investment in Henry Schein, a leading provider of healthcare products and services to office-based dental and medical practitioners, highlights the continued attractiveness of the healthcare distribution and services sector to large private equity firms. This move suggests a belief in the long-term growth potential of the dental and medical markets, potentially driven by demographic trends, technological advancements, and consolidation opportunities. KKR's strategic partnership approach, including board representation, indicates a hands-on investment strategy aimed at influencing the company's strategic trajectory within the competitive healthcare industry.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Related Party Transactions

• Tarheel Investors II L.P., an affiliate of the Reporting Persons, transferred 11,628,344 shares of Common Stock to KKR Hawaii Aggregator L.P. on March 13, 2025, which were received upon physical settlement of a total return swap. This is an internal transfer within the KKR group of entities.

Stakeholder Impact

• Shareholders: The private placement could lead to minor dilution but also signals strong institutional confidence and provides capital for growth. KKR's board representation may lead to enhanced strategic direction and potentially improved shareholder value.
• Employees: No direct impact mentioned, but a strong strategic partner could lead to long-term stability and growth opportunities.
• Customers: No direct impact mentioned, but a stronger Henry Schein could lead to better products/services.
• Suppliers: No direct impact mentioned.
• Creditors: The capital raise strengthens the balance sheet, potentially improving creditworthiness.

Next Steps

• Satisfaction of regulatory conditions (Hart-Scott-Rodino Antitrust Improvements Act and foreign regulatory approvals) for the private placement and Max Lin's board appointment.
• Appointment of Max Lin to the Board of Directors and its Nominating and Governance Committee (as Vice Chair) and Strategic Advisory Committee.
• Acquisition by KKR of beneficial ownership and voting power over at least 11,978,510 shares of Common Stock for William K. 'Dan' Daniel's board appointment.
• Appointment of William K. 'Dan' Daniel to the Board of Directors and its Compensation Committee and Strategic Advisory Committee.
• Nomination of both Max Lin and William K. 'Dan' Daniel by the Board to stand for election at the 2025 Annual Meeting of stockholders.
• Entry into a Registration Rights Agreement between Henry Schein and KKR Hawaii Aggregator L.P. on the closing date of the Investment.
• Potential future acquisition or disposition of additional shares of Common Stock by KKR, subject to market conditions and agreements.
• Ongoing discussions between KKR and Henry Schein's management and board regarding business, operations, strategy, plans, and prospects.

Key Dates

Recommendation

Keywords

Henry Schein, KKR, Private Equity, Investment, Strategic Partnership, Board of Directors, Shareholder, SEC Filing, Schedule 13D, Healthcare, Dental, Medical, Corporate Governance, Capital Raise